Genencor is amongst the largest developers and manufacturers of industrial enzymes and the second largest biotechnology company in the world. Genencor discovers, develops, manufactures, and delivers eco-friendly, efficient enzyme product solutions for the agri processing, cleaning and textiles, food and feed, consumer, and industrial markets. We also develop innovative advancements for the biofuels, biodefense, and biosafety industries. We are a recognized leader in protein and pathway engineering. No other biotechnology company offers the breadth of skills and experience that we do to deliver total solutions to a broad array of markets.
Genencor – It’s All About You
Ageing: Much ado about ageing
Ageing: Much ado about ageing
Questions about a laboratory assay are making Sirtris, a high-profile biotechnology company, the talking point of the ageing field. Heidi Ledford investigates.
Read more on Nature
Invida to continue commercialization of Actelion’s Tracleer for PAH in crucial Asian markets
Invida to continue commercialization of Actelion’s Tracleer for PAH in crucial Asian markets
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has …
Read more on News-Medical-Net